AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC
Clinical trial NCT06196814 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06196814
- Sponsor
- Hunan Province Tumor Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2026-03-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.